Catalyst Wire Dossier Catalyst Wire Dossier

NKTR-181

· Nektar Therapeutics
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NKTR-181, covering 2020-09-16 to 2021-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain [Phase 2]

See pricing